Freddie Sherlock is an accomplished scientist with a strong background in cancer cell biology and significant experience in pharmaceutical and biotechnology research. At AstraZeneca, Freddie served as both a Scientist and Senior Scientist from September 2023 to July 2025, contributing to advanced projects in Cambridge, England. Prior to this role, Freddie worked at Avacta as a Research Associate and later as a Senior Research Associate from April 2019 to January 2021. Most recently, Freddie held the position of Scientist at BenevolentAI from May 2022 to September 2023. Academic credentials include a Master of Science in Cancer Cell Biology with Merit and a Bachelor of Science in Biology/Biological Sciences with a 2:1, both from the University of Sussex. Freddie's educational journey also includes experiences at Bangkok Patana School, St George's British International School in Rome, and the British International School in Jakarta.
This person is not in the org chart
This person is not in any teams
This person is not in any offices